申请人:Araxes Pharma LLC
公开号:US20180162812A1
公开(公告)日:2018-06-14
Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.